| CXSB2000050 | SHR-1222注射液 | SHR-1222 | Injection | Biological Products(1) | Supplementary Application | 2020-09-05 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | In Review | 2020-09-04 | view |
| CXSB2000023 | SHR-1314注射液 | vunakizumab | Injection | Biological Products | Supplementary Application | 2020-06-30 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd;Jiangsu Hengrui Pharmaceuticals Co Ltd;Shanghai Hengrui Pharmaceutical Co Ltd | In Review | 2020-11-11 | view |
| CXSL2000253 | SHR-1314注射液 | vunakizumab | Injection | Biological Products(1) | New Drug Application | 2020-09-01 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | In Review | 2020-08-31 | view |
| CXSB2000116 | SHR-1314注射液 | vunakizumab | Injection | Biological Products(1) | Supplementary Application | 2020-12-02 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | In Review | 2020-12-01 | view |
| CXSL2100042 | SHR-1314注射液 | vunakizumab | Injection | Biological Products(1) | New Drug Application | 2021-02-03 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | In Review | 2021-02-03 | view |
| CXSL2000040 | SHR-1316注射液 | Adebrelimab | Injection | Biological Products(1) | New Drug Application | 2020-03-07 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | In Review | 2020-03-06 | view |
| CXSL1900113 | SHR-1316注射液 | Adebrelimab | Injection | Biological Products(1) | New Drug Application | 2019-10-24 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | In Review | 2019-10-23 | view |
| CXSL2000099 | SHR-1316注射液 | Adebrelimab | Injection | Biological Products(1) | New Drug Application | 2020-05-15 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | In Review | 2020-05-14 | view |
| CXSL1900106 | SHR-1316注射液 | Adebrelimab | Injection | Biological Products(1) | New Drug Application | 2019-09-25 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | In Review | 2019-09-24 | view |
| CXSL2000071 | SHR-1316注射液 | Adebrelimab | Injection | Biological Products(1) | New Drug Application | 2020-04-17 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | In Review | 2020-04-16 | view |
| CXSL2100017 | SHR-1701注射液 | retlirafusp alfa | Injection | Biological Products(1) | New Drug Application | 2021-01-19 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | In Review | 2021-01-19 | view |
| CXSL2000366 | SHR-1701注射液 | retlirafusp alfa | Injection | Biological Products(1) | New Drug Application | 2020-12-18 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | In Review | 2020-12-17 | view |
| CXSL2000301 | SHR-1701注射液 | retlirafusp alfa | Injection | Biological Products(1) | New Drug Application | 2020-10-27 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | In Review | 2020-10-26 | view |
| CXSB2000134 | SHR-1701注射液 | retlirafusp alfa | Injection | Biological Products(1) | Supplementary Application | 2020-12-14 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | In Review | 2020-12-11 | view |
| CXSL2000300 | SHR-1701注射液 | retlirafusp alfa | Injection | Biological Products(1) | New Drug Application | 2020-10-27 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | In Review | 2020-10-26 | view |
| CXSL1800018 | 注射用SHR-1209 | recaticimab | Lyophilized | Biological Products(1) | New Drug Application | 2018-03-05 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | Certificate Issued | 2018-06-28 | view |
| CXSL1700113 | 注射用SHR-1501 | SHR-1501 | Lyophilized | Biological Products(1) | New Drug Application | 2017-12-18 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | Certificate Issued | 2018-05-17 | view |
| CXSL1900030 | 注射用卡瑞利珠单抗 | camrelizumab | Lyophilized | Biological Products(1) | New Drug Application | 2019-03-26 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | In Review | 2019-03-25 | view |
| CXSL2100079 | 注射用卡瑞利珠单抗 | camrelizumab | Lyophilized | Biological Products(2.2) | New Drug Application | 2021-03-03 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | In Review | 2021-03-02 | view |
| CXSB1900021 | 注射用卡瑞利珠单抗 | camrelizumab | Lyophilized | Biological Products | Supplementary Application | 2019-09-12 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd;Jiangsu Hengrui Pharmaceuticals Co Ltd;Shanghai Hengrui Pharmaceutical Co Ltd | Certificate Issued | 2019-11-28 | view |
